The pressure to deliver novel therapeutics to people is constantly increasing, and biopharmaceutical companies are increasingly utilizing specialized identification and development services to expedite the entire process. These solutions encompass a wide spectrum of capabilities, from early-stage target identification and lead improvement to pre-cl